Durability of Antibody Response Against the Hepatitis B Virus in Kidney Transplant Recipients: A Proposed Immunization Guideline From a 3-Year Follow-up Clinical Study | Zendy

Wiwat Chancharoenthana | Zendy; Asada Leelahavanichkul | Zendy; Suwasin Udomkarnjananun | Zendy; Salin Wattanatorn | Zendy; Yingyos Avihingsa | Zendy; Kearkiat Praditpornsilpa | Zendy; Kriang Tungsanga | Zendy; Somchai EiamOng | Zendy; Natavudh Townamchai | Zendy

Open Access

Durability of Antibody Response Against the Hepatitis B Virus in Kidney Transplant Recipients: A Proposed Immunization Guideline From a 3-Year Follow-up Clinical Study

Author(s) -

Wiwat Chancharoenthana,

Asada Leelahavanichkul,

Suwasin Udomkarnjananun,

Salin Wattanatorn,

Yingyos Avihingsa,

Kearkiat Praditpornsilpa,

Kriang Tungsanga,

Somchai EiamOng,

Natavudh Townamchai

Publication year - 2018

Publication title -

open forum infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.546

H-Index - 35

ISSN - 2328-8957

DOI - 10.1093/ofid/ofy342

Subject(s) - medicine , guideline , immunization , kidney transplant , antibody , kidney transplantation , immunology , virology , antibody response , hepatitis b virus , virus , transplantation , pathology

To ensure optimal immunity against HBV, KT recipients should first be stratified according to their risk of HBV reactivation. Kidney transplantation recipients of renal allografts from HBV nonviremic or viremic donors should be reimmunized when their anti-HBsAb titers are <250 IU/L. A cutoff level of 100 IU/L is recommended in other cases.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research